Inhibition of GSK-3 ameliorates the pathogenesis of Huntington's disease

Ido Rippin, Katherina Bonder, Shirley Joseph, Ammar Sarsor, Lilach Vaks, Hagit Eldar-Finkelman*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

16 Scopus citations

Fingerprint

Dive into the research topics of 'Inhibition of GSK-3 ameliorates the pathogenesis of Huntington's disease'. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry

Neuroscience

Immunology and Microbiology

Pharmacology, Toxicology and Pharmaceutical Science

Biochemistry, Genetics and Molecular Biology